LCDs Demonstrate Evolving Coverage of Molecular Diagnostics

Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for payors as far as coverage is concerned. Normally the most cautious of payors, Medicare has demonstrated an increasing willingness to cover newfangled tests—at least in certain circumstances—with the expectation that they do work…